May 13, 2024 Experience NatWest Group $1 billion contingent convertible Additional Tier 1 notes We advised NatWest Group on the SEC-registered offering
May 8, 2024 Experience ADC Therapeutics $105 million follow-on offering We advised ADC Therapeutics on its offering of shares and pre-funded warrants
May 7, 2024 Experience GXO Logistics $1.1 billion notes offering The investment-grade notes are due 2029 and 2034
April 29, 2024 Experience CaixaBank $2 billion notes offering under $7.5 billion U.S. MTN program The offering involved senior non-preferred callable fixed-to-floating-rate notes due 2030 and 2035
April 22, 2024 Experience Avolta €500 million notes offering and cash tender offer We advised Avolta on its high-yield notes offering and tender offer
April 19, 2024 Experience Barratt Developments £2.52 billion all-share offer for Redrow We are advising UBS as financial adviser and sponsor to Barratt Developments on the transaction
April 1, 2024 Experience Nuvei $6.3 billion going-private acquisition We are advising Nuvei on the transaction
March 25, 2024 Experience Galderma Group CHF2.3 billion ($2.6 billion) IPO We advised Galderma on its IPO
March 22, 2024 Experience JPMorgan Chase €2 billion notes offering We advised JPMorgan Chase on the euro notes offering